These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


162 related items for PubMed ID: 1608203

  • 21. Cost effectiveness of radiofrequency catheter ablation versus medical treatment for paroxysmal supraventricular tachycardia in Japan.
    Ikeda T, Sugi K, Enjoji Y, Kasao M, Abe R, Ninomiya K, Yabuki S, Yamaguchi T.
    J Cardiol; 1994; 24(6):461-8. PubMed ID: 7823285
    [Abstract] [Full Text] [Related]

  • 22. [Efficacy and safety of adenosine triphosphate in the control of supraventricular paroxysmal tachycardia].
    Brandão L, de Sousa J, Barreiros MC, Vagueiro MC, Amram SS.
    Rev Port Cardiol; 1994 Mar; 13(3):197-202, 191. PubMed ID: 8049086
    [Abstract] [Full Text] [Related]

  • 23. [Usefulness of the pre-excitation index to determine the mechanism of supraventricular paroxysmal tachycardia and the location of the anomalous pathway].
    Hernández González D, Iturralde Torres P, Colín L, Gutiérrez A, González Hermosillo JA.
    Arch Inst Cardiol Mex; 1990 Mar; 60(2):145-52. PubMed ID: 2378534
    [Abstract] [Full Text] [Related]

  • 24. Clinical value of cordarone as an antiarrhythmic agent.
    Piwowarska W, Sniezek-Maciejewska M.
    Cor Vasa; 1987 Mar; 29(4):269-77. PubMed ID: 2445525
    [Abstract] [Full Text] [Related]

  • 25. Adenosine-induced cardiopulmonary arrest in a patient with paroxysmal supraventricular tachycardia--a response.
    Jenkins NS, Knights M, Eickmann C, Payne M.
    Am J Emerg Med; 2010 May; 28(4):526; author reply 526-7. PubMed ID: 20466244
    [No Abstract] [Full Text] [Related]

  • 26. [The anti-arrhythmia effect and hemodynamic effects of Bonnecor in intravenous administration].
    Volkmann H, Kühnert H, Dannberg G, Küch N, Büttner A.
    Z Gesamte Inn Med; 1989 Dec 01; 44(23):707-11. PubMed ID: 2629366
    [Abstract] [Full Text] [Related]

  • 27. [Bepridil in the treatment of supraventricular paroxysmal tachycardias].
    Medvedowsky JL, Barnay C, Arnaud C, Bonet P, Quittet F, Lam LF.
    Arch Mal Coeur Vaiss; 1985 Oct 01; 78 Spec No():67-74. PubMed ID: 3938262
    [Abstract] [Full Text] [Related]

  • 28. [The usefulness of adenosine triphosphate in supraventricular paroxysmal tachycardias].
    Jornet A, Palet J, Usón M, Petit M.
    Rev Clin Esp; 1993 Feb 01; 192(2):70-2. PubMed ID: 8460236
    [Abstract] [Full Text] [Related]

  • 29. [Effects of rotundium on clinical electrophysiology in patients with pre-excitation syndrome].
    Wang DJ.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Oct 01; 21(5):286-7, 316. PubMed ID: 8200311
    [Abstract] [Full Text] [Related]

  • 30. Intravenous tetrandrine in terminating acute episodes of paroxysmal supraventricular tachycardia.
    Dai GZ, Zeng B, Zhang YL, Lu YX.
    Chin Med J (Engl); 1990 Jun 01; 103(6):460-3. PubMed ID: 2119958
    [Abstract] [Full Text] [Related]

  • 31. [Electrophysiological evaluation of anti-arrhythmia therapy in patients with recurrent supraventricular and ventricular tachycardia].
    Fajuri A, González R, Diáz R, Arriagada D, Corbalán R.
    Rev Med Chil; 1983 Nov 01; 111(11):1117-22. PubMed ID: 6678454
    [No Abstract] [Full Text] [Related]

  • 32. Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia.
    Ballo P, Bernabò D, Faraguti SA.
    Eur Heart J; 2004 Aug 01; 25(15):1310-7. PubMed ID: 15288158
    [Abstract] [Full Text] [Related]

  • 33. [Electrophysiologic testing and effects of antiarrhythmic drugs in patients with paroxysmal supraventricular tachycardia].
    Atarashi H, Ino T, Hayakawa H.
    Jpn Circ J; 1992 Aug 01; 56 Suppl 5():1451-3. PubMed ID: 1291740
    [No Abstract] [Full Text] [Related]

  • 34. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
    Circulation; 1995 Nov 01; 92(9):2550-7. PubMed ID: 7586356
    [Abstract] [Full Text] [Related]

  • 35. [Treatment of supraventricular and paroxysmal ventricular tachycardia with bepridil].
    Fauchier JP, Cosnay P, Néel C, Rouesnel P, Bonnet P, Quilliet L.
    Arch Mal Coeur Vaiss; 1985 Apr 01; 78(4):612-9. PubMed ID: 3923987
    [Abstract] [Full Text] [Related]

  • 36. [The treatment of paroxysmal supraventricular arrhythmias in IHD patients with a high risk of developing complications from the anti-arrhythmic therapy].
    Andriushchenko OM, Olesin AI.
    Ter Arkh; 1996 Apr 01; 68(5):57-60. PubMed ID: 9082603
    [Abstract] [Full Text] [Related]

  • 37. [Adenosine triphosphate in the treatment of supraventricular paroxysmal tachycardia].
    Botas Rodríguez J, Almazán Ceballos A, Pérez Pandelo R, San Román Sánchez D, Quiroga Marañón J, Abeytua Jiménez M, Penas Cortés J.
    Rev Esp Cardiol; 1987 Apr 01; 40(6):431-3. PubMed ID: 3454992
    [No Abstract] [Full Text] [Related]

  • 38. [The clinical cardiac electrophysiologic effects of tetrandrine].
    Li WH.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Aug 01; 21(4):225-6, 254. PubMed ID: 8194436
    [Abstract] [Full Text] [Related]

  • 39. [Treatment with adenosine for supraventricular paroxysmal tachycardia during pregnancy].
    Varela Aguilar JM, González-Jiménez MD, García-Contreras R, González de la Fuente MA.
    Med Clin (Barc); 1997 Jun 21; 109(4):159. PubMed ID: 9289536
    [No Abstract] [Full Text] [Related]

  • 40. [Amiodarone-induced hyperthyroidism causing progression of arrhythmia].
    Pintér A, Zámolyi K, Székely A, Préda I.
    Orv Hetil; 1994 Jul 10; 135(28):1535-8. PubMed ID: 8058296
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.